Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Vanda Pharmaceutical (VNDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 584,090
  • Shares Outstanding, K 44,930
  • Annual Sales, $ 146,020 K
  • Annual Income, $ -18,010 K
  • 36-Month Beta 1.36
  • Price/Sales 4.05
  • Price/Cash Flow 0.00
  • Price/Book 4.52

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.90 +9.24%
on 11/13/17
16.20 -19.75%
on 11/06/17
-3.00 (-18.75%)
since 10/20/17
3-Month
11.90 +9.24%
on 11/13/17
18.99 -31.54%
on 09/21/17
-2.95 (-18.50%)
since 08/22/17
52-Week
11.90 +9.24%
on 11/13/17
18.99 -31.54%
on 09/21/17
-3.75 (-22.39%)
since 11/22/16

Most Recent Stories

More News
Vanda Pharmaceuticals Announces Participation at November 2017 Investor Conferences

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it will participate at the following upcoming investor conferences in November 2017.

VNDA : 13.00 (-1.14%)
Vanda Receives Negative Opinion for Marketing Authorization from the European Medicines Agency on Fanaptum(TM) for the Treatment of Schizophrenia

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) announced today the refusal of the marketing authorization application (MAA) of Fanaptum(TM) (oral iloperidone tablets) for the treatment of schizophrenia...

VNDA : 13.00 (-1.14%)
Vanda Pharmaceuticals Reports Third Quarter 2017 Financial Results

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced financial and operational results for the third quarter ended September 30, 2017.

VNDA : 13.00 (-1.14%)
Vanda Pharmaceuticals Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 7, 2017 / Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) will be discussing their earnings results in their Q3 Earnings Call to be held on November 7, 2017 at 4:30 PM Eastern...

VNDA : 13.00 (-1.14%)
Vanda Pharmaceuticals Announces Participation at the Oppenheimer Specialty Pharma Summit Conference

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that it will host investor meetings at the Oppenheimer Specialty Pharma Summit Conference in New York City on Wednesday, October 11, 2017....

VNDA : 13.00 (-1.14%)
Vanda to Present Tradipitant Phase II Atopic Dermatitis Data at World Congress of Itch

Vanda Pharmaceuticals Inc. (VANDA) (NASDAQ: VNDA) today announced that data from the results of the Phase II study of tradipitant in atopic dermatitis will be presented at the 9th World Congress of Itch...

VNDA : 13.00 (-1.14%)
Vanda to Present Scientific Posters at World Sleep 2017

Vanda Pharmaceuticals Inc. (VANDA) (NASDAQ: VNDA) today announced participation at the 2017 joint congress of World Association of Sleep Medicine and World Sleep Federation (World Sleep 2017) in Prague,...

VNDA : 13.00 (-1.14%)
Technical Reports on Biotech Equities -- Vanda Pharma, ACADIA Pharma, Achillion Pharma, and Agios Pharma

If you want a Stock Review on VNDA, ACAD, ACHN, or AGIO then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. For today, DailyStockTracker.com monitors Vanda...

AGIO : 61.30 (+1.86%)
ACHN : 3.36 (-2.04%)
ACAD : 28.25 (+1.29%)
VNDA : 13.00 (-1.14%)
Vanda's Tradipitant Improves Itch and Disease Severity in Patients with Atopic Dermatitis

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced results from an 8-week randomized Phase II clinical study of tradipitant as a monotherapy in the treatment of chronic pruritus in patients...

VNDA : 13.00 (-1.14%)
Vanda Pharmaceuticals Announces Participation at September 2017 Investor Conferences

Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that it will participate at the following upcoming investor conferences in September 2017.

VNDA : 13.00 (-1.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. It is developing important new medicines to improve the lives of patients. It uses new technologies, including genetics...

See More

Key Turning Points

2nd Resistance Point 13.27
1st Resistance Point 13.13
Last Price 13.00
1st Support Level 12.93
2nd Support Level 12.87

See More

52-Week High 18.99
Fibonacci 61.8% 16.28
Fibonacci 50% 15.44
Fibonacci 38.2% 14.61
Last Price 13.00
52-Week Low 11.90

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart